| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a8f70c5b59b293a0220e30a752bb017f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-422
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-10 |
| filingDate |
2007-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98b55cd43db2bd969adbbf14fc8c5094
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d08f1812f4d495661d732722d284830
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e888a37dad97e729f2af981fef9f79f |
| publicationDate |
2009-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2072514-A1 |
| titleOfInvention |
1(2)H-tetrazol-5-yl-phenyl-oxazolidinones as antibacterial agents |
| abstract |
The present invention provides a class of phenyl-oxazolidinones of formula (I):n nor a pharmaceutically acceptable salt thereof, wherein: nR 1 is a radical of formula (i) or formula (ii):n nmethods of preparing such compounds, pharmaceutical compositions comprising one or more of such compounds, and the use thereof in the manufacture of a medicament which is used in the treatment of bacterial infections. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011111971-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011111971-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101128029-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8703939-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012121424-A1 |
| priorityDate |
2007-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |